Population Pharmacokinetic/Pharmacodynamic Analyses as the Basis for Dosing of Therapeutic Monoclonal Antibodies

被引:4
|
作者
Meibohm, Bernd [1 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA
关键词
MODEL;
D O I
10.2165/11597950-000000000-00000
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:823 / 824
页数:2
相关论文
共 50 条
  • [1] Population Pharmacokinetic/Pharmacodynamic Analyses as the Basis for Dosing of Therapeutic Monoclonal Antibodies
    Bernd Meibohm
    Clinical Pharmacokinetics, 2011, 50 : 823 - 824
  • [2] Pharmacokinetic and Pharmacodynamic Basis for Effective Argatroban Dosing in Pediatrics
    Madabushi, Rajanikanth
    Cox, Donna S.
    Hossain, Mohammad
    Boyle, Duane A.
    Patel, Bela R.
    Young, Guy
    Choi, Young-Moon
    Gobburu, Jogarao V. S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01): : 19 - 28
  • [3] Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations
    Chan, Phyllis
    Mould, Diane R.
    Abu Tarif, Malaz
    Reynolds, Laurie
    LaCreta, Frank
    Bertz, Richard
    Bifano, Marc
    CLINICAL PHARMACOKINETICS, 2016, 55 (12) : 1559 - 1572
  • [4] Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations
    Phyllis Chan
    Diane R. Mould
    Malaz Abu Tarif
    Laurie Reynolds
    Frank LaCreta
    Richard Bertz
    Marc Bifano
    Clinical Pharmacokinetics, 2016, 55 : 1559 - 1572
  • [5] Pharmacokinetic and Pharmacodynamic Considerations in the Design of Therapeutic Antibodies
    Leipold, Douglas
    Prabhu, Saileta
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (02): : 130 - 139
  • [6] Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling
    Admiraal, Rick
    van Kesteren, Charlotte
    Boelens, Jaap Jan
    Bredius, Robbert G. M.
    Tibboel, Dick
    Knibbe, Catherijne A. J.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (03) : 267 - 272
  • [7] Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Relationships of Monoclonal Antibodies in Children
    Helena Edlund
    Johanna Melin
    Zinnia P. Parra-Guillen
    Charlotte Kloft
    Clinical Pharmacokinetics, 2015, 54 : 35 - 80
  • [8] Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies
    Desnoyer, Aude
    Broutin, Sophie
    Delahousse, Julia
    Maritaz, Christophe
    Blondel, Louis
    Mir, Olivier
    Chaput, Nathalie
    Paci, Angelo
    EUROPEAN JOURNAL OF CANCER, 2020, 128 : 119 - 128
  • [9] Pharmacokinetic, pharmacodynamic and immunogenicity comparability assessment strategies for monoclonal antibodies
    Putnam, Wendy S.
    Prabhu, Saileta
    Zheng, Yanan
    Subramanyam, Meena
    Wang, Yow-Ming C.
    TRENDS IN BIOTECHNOLOGY, 2010, 28 (10) : 509 - 516
  • [10] Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships of Monoclonal Antibodies in Children
    Edlund, Helena
    Melin, Johanna
    Parra-Guillen, Zinnia P.
    Kloft, Charlotte
    CLINICAL PHARMACOKINETICS, 2015, 54 (01) : 35 - 80